Literature DB >> 32513729

Employing NaChBac for cryo-EM analysis of toxin action on voltage-gated Na+ channels in nanodisc.

Shuai Gao1, William C Valinsky2, Nguyen Cam On1, Patrick R Houlihan2, Qian Qu3, Lei Liu3, Xiaojing Pan4, David E Clapham2, Nieng Yan5.   

Abstract

NaChBac, the first bacterial voltage-gated Na+ (Nav) channel to be characterized, has been the prokaryotic prototype for studying the structure-function relationship of Nav channels. Discovered nearly two decades ago, the structure of NaChBac has not been determined. Here we present the single particle electron cryomicroscopy (cryo-EM) analysis of NaChBac in both detergent micelles and nanodiscs. Under both conditions, the conformation of NaChBac is nearly identical to that of the potentially inactivated NavAb. Determining the structure of NaChBac in nanodiscs enabled us to examine gating modifier toxins (GMTs) of Nav channels in lipid bilayers. To study GMTs in mammalian Nav channels, we generated a chimera in which the extracellular fragment of the S3 and S4 segments in the second voltage-sensing domain from Nav1.7 replaced the corresponding sequence in NaChBac. Cryo-EM structures of the nanodisc-embedded chimera alone and in complex with HuwenToxin IV (HWTX-IV) were determined to 3.5 and 3.2 Å resolutions, respectively. Compared to the structure of HWTX-IV-bound human Nav1.7, which was obtained at an overall resolution of 3.2 Å, the local resolution of the toxin has been improved from ∼6 to ∼4 Å. This resolution enabled visualization of toxin docking. NaChBac can thus serve as a convenient surrogate for structural studies of the interactions between GMTs and Nav channels in a membrane environment.

Entities:  

Keywords:  NaChBac; Nav channels; electron cryomicroscopy (cryo-EM); gating modifier toxins; nanodisc

Year:  2020        PMID: 32513729      PMCID: PMC7322032          DOI: 10.1073/pnas.1922903117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  Sodium channel β subunits: emerging targets in channelopathies.

Authors:  Heather A O'Malley; Lori L Isom
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

3.  Common molecular determinants of tarantula huwentoxin-IV inhibition of Na+ channel voltage sensors in domains II and IV.

Authors:  Yucheng Xiao; James O Jackson; Songping Liang; Theodore R Cummins
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

4.  Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.

Authors:  Shivani Ahuja; Susmith Mukund; Lunbin Deng; Kuldip Khakh; Elaine Chang; Hoangdung Ho; Stephanie Shriver; Clint Young; Sophia Lin; J P Johnson; Ping Wu; Jun Li; Mary Coons; Christine Tam; Bobby Brillantes; Honorio Sampang; Kyle Mortara; Krista K Bowman; Kevin R Clark; Alberto Estevez; Zhiwei Xie; Henry Verschoof; Michael Grimwood; Christoph Dehnhardt; Jean-Christophe Andrez; Thilo Focken; Daniel P Sutherlin; Brian S Safina; Melissa A Starovasnik; Daniel F Ortwine; Yvonne Franke; Charles J Cohen; David H Hackos; Christopher M Koth; Jian Payandeh
Journal:  Science       Date:  2015-12-18       Impact factor: 47.728

5.  Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7.

Authors:  Akello J Agwa; Nicole Lawrence; Evelyne Deplazes; Olivier Cheneval; Rachel M Chen; David J Craik; Christina I Schroeder; Sónia T Henriques
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-20       Impact factor: 3.747

6.  A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site.

Authors:  Ramkumar Rajamani; Sophie Wu; Iyoncy Rodrigo; Mian Gao; Simon Low; Lisa Megson; David Wensel; Rick L Pieschl; Debra J Post-Munson; John Watson; David R Langley; Michael K Ahlijanian; Linda J Bristow; James Herrington
Journal:  Mol Pharmacol       Date:  2017-06-23       Impact factor: 4.436

7.  Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.

Authors:  Y P Goldberg; J MacFarlane; M L MacDonald; J Thompson; M-P Dube; M Mattice; R Fraser; C Young; S Hossain; T Pape; B Payne; C Radomski; G Donaldson; E Ives; J Cox; H B Younghusband; R Green; A Duff; E Boltshauser; G A Grinspan; J H Dimon; B G Sibley; G Andria; E Toscano; J Kerdraon; D Bowsher; S N Pimstone; M E Samuels; R Sherrington; M R Hayden
Journal:  Clin Genet       Date:  2007-04       Impact factor: 4.438

8.  Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.

Authors:  Mohammed A Nassar; L Caroline Stirling; Greta Forlani; Mark D Baker; Elizabeth A Matthews; Anthony H Dickenson; John N Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

9.  Structure of a bacterial voltage-gated sodium channel pore reveals mechanisms of opening and closing.

Authors:  Emily C McCusker; Claire Bagnéris; Claire E Naylor; Ambrose R Cole; Nazzareno D'Avanzo; Colin G Nichols; B A Wallace
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 10.  Voltage gated sodium channels as drug discovery targets.

Authors:  Sharan K Bagal; Brian E Marron; Robert M Owen; R Ian Storer; Nigel A Swain
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

View more
  9 in total

1.  Synthetic Analogues of Huwentoxin-IV Spider Peptide With Altered Human NaV1.7/NaV1.6 Selectivity Ratios.

Authors:  Ludivine Lopez; Jérôme Montnach; Barbara Oliveira-Mendes; Kuldip Khakh; Baptiste Thomas; Sophia Lin; Cécile Caumes; Steven Wesolowski; Sébastien Nicolas; Denis Servent; Charles Cohen; Rémy Béroud; Evelyne Benoit; Michel De Waard
Journal:  Front Cell Dev Biol       Date:  2021-12-20

2.  Structural Basis for High-Affinity Trapping of the NaV1.7 Channel in Its Resting State by Tarantula Toxin.

Authors:  Goragot Wisedchaisri; Lige Tonggu; Tamer M Gamal El-Din; Eedann McCord; Ning Zheng; William A Catterall
Journal:  Mol Cell       Date:  2020-11-23       Impact factor: 17.970

3.  Selective Targeting of Nav1.7 with Engineered Spider Venom-Based Peptides.

Authors:  Robert A Neff; Alan D Wickenden
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

Review 4.  Druggability of Voltage-Gated Sodium Channels-Exploring Old and New Drug Receptor Sites.

Authors:  Goragot Wisedchaisri; Tamer M Gamal El-Din
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

5.  Molecular mechanism of the spider toxin κ-LhTx-I acting on the bacterial voltage-gated sodium channel NaChBac.

Authors:  Zhen Xiao; Yaqi Li; Piao Zhao; Xiangyue Wu; Guoqing Luo; Shuijiao Peng; Hongrong Liu; Cheng Tang; Zhonghua Liu
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

6.  The T1-tetramerisation domain of Kv1.2 rescues expression and preserves function of a truncated NaChBac sodium channel.

Authors:  Nazzareno D'Avanzo; Andrew J Miles; Andrew M Powl; Colin G Nichols; B A Wallace; Andrias O O'Reilly
Journal:  FEBS Lett       Date:  2022-01-19       Impact factor: 3.864

Review 7.  Assessing the Role of Lipids in the Molecular Mechanism of Membrane Proteins.

Authors:  Léni Jodaitis; Thomas van Oene; Chloé Martens
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

8.  Potency-Enhancing Mutations of Gating Modifier Toxins for the Voltage-Gated Sodium Channel NaV1.7 Can Be Predicted Using Accurate Free-Energy Calculations.

Authors:  Dana Katz; Dan Sindhikara; Michael DiMattia; Abba E Leffler
Journal:  Toxins (Basel)       Date:  2021-03-07       Impact factor: 4.546

9.  Regulation and drug modulation of a voltage-gated sodium channel: Pivotal role of the S4-S5 linker in activation and slow inactivation.

Authors:  Jinglei Xiao; Vasyl Bondarenko; Yali Wang; Antonio Suma; Marta Wells; Qiang Chen; Tommy Tillman; Yan Luo; Buwei Yu; William P Dailey; Roderic Eckenhoff; Pei Tang; Vincenzo Carnevale; Michael L Klein; Yan Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.